Immunodeficiency, Injection Drug Use Linked to Failed HCV Treatment in People with HIV
New research is shining light on the efficacy of direct-acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) in people with human immunodeficiency virus (HIV), highlighting a 95% treatment success rate in this patient population and …